Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1171932

SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study


(COVIDSurg Collaborative ; GlobalSurg Collaborative) COVIDSurg Collaborative; GlobalSurg Collaborative
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study // Anaesthesia, 77 (2022), 1; 28-39 doi:10.1111/anae.15563 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1171932 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

Autori
COVIDSurg Collaborative ; GlobalSurg Collaborative

Kolaboracija
COVIDSurg Collaborative ; GlobalSurg Collaborative

Izvornik
Anaesthesia (0003-2409) 77 (2022), 1; 28-39

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
COVID-19 ; SARS-CoV-2 ; deep vein thrombosis ; pulmonary embolism ; venous thromboembolism

Sažetak
SARS-CoV-2 has been associated with an increased rate of venous thromboembolism in critically ill patients. Since surgical patients are already at higher risk of venous thromboembolism than general populations, this study aimed to determine if patients with peri- operative or prior SARS-CoV-2 were at further increased risk of venous thromboembolism. We conducted a planned sub-study and analysis from an international, multicentre, prospective cohort study of elective and emergency patients undergoing surgery during October 2020. Patients from all surgical specialties were included. The primary outcome measure was venous thromboembolism (pulmonary embolism or deep vein thrombosis) within 30 days of surgery. SARS-CoV-2 diagnosis was defined as peri- operative (7 days before to 30 days after surgery) ; recent (1-6 weeks before surgery) ; previous (≥7 weeks before surgery) ; or none. Information on prophylaxis regimens or pre-operative anti- coagulation for baseline comorbidities was not available. Postoperative venous thromboembolism rate was 0.5% (666/123, 591) in patients without SARS-CoV- 2 ; 2.2% (50/2317) in patients with peri-operative SARS- CoV-2 ; 1.6% (15/953) in patients with recent SARS- CoV-2 ; and 1.0% (11/1148) in patients with previous SARS-CoV-2. After adjustment for confounding factors, patients with peri-operative (adjusted odds ratio 1.5 (95%CI 1.1-2.0)) and recent SARS-CoV-2 (1.9 (95%CI 1.2- 3.3)) remained at higher risk of venous thromboembolism, with a borderline finding in previous SARS-CoV-2 (1.7 (95%CI 0.9-3.0)). Overall, venous thromboembolism was independently associated with 30-day mortality (5.4 (95%CI 4.3- 6.7)). In patients with SARS-CoV- 2, mortality without venous thromboembolism was 7.4% (319/4342) and with venous thromboembolism was 40.8% (31/76). Patients undergoing surgery with peri-operative or recent SARS-CoV-2 appear to be at increased risk of postoperative venous thromboembolism compared with patients with no history of SARS-CoV-2 infection. Optimal venous thromboembolism prophylaxis and treatment are unknown in this cohort of patients, and these data should be interpreted accordingly.

Izvorni jezik
Engleski

Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)

Napomena
Autori na kolaboraciji navedeni na kraju rada (Appendix S1 - GlobalSurg-CovidSurg Week Authorship)
Writing group:
Arnaud, Alexis P.; Moreira de Azevedo, José; Minaya Bravo, Ana Maria; Chaudhry, Daoud; AlAmeer, Ehab; El-Boghdadly, Kariem; Elhadi, Muhammed; Emile, Sameh; Gallo, Gaetano;
Glasbey, James C.; Ghosh, Dhruva; Isik, Arda; Jones, Conor S.; Leventoğlu, Sezai; Li, Elizabeth; Martin, Janet; Mohan, Helen; Nepogodiev, Dmitri; Pawar, Pranay; Smart, Neil;
Pockney, Peter; Simoes, Joana F. F.; Tabiri, Stephen; Venn, Mary L.; Wright, Deborah; Bhangu, Aneel
Dissemination Committee:
Croatia: Ana Đanić Hadžibegović, Tomislav Kopjar, Jakov Mihanović
Hospital Leads:
Croatia: Jakov Mihanović (Zadar General Hospital, Zadar)
Local Collaborators:
Croatia: Kristina Bitunjac, Karlo Grulović, Marijana Vučković (General and Veterans Hospital ‘Hrvatski Ponos’ Knin, Knin); Goran Šantak (County General Hospital Pozega, Pozega);
Emanuel Borovic, Ana Bosak Versic, Damir Hasandić, Natasa Poldan Grabar, Suzana Srsen Medancic (University Hospital Center Rijeka, Rijeka); Lucija Brkic, Sara Cokarić, Petra
Pavic Palac, Zeljka Samac, Josipa Tomić, Marija Vrdoljak (General Hospital Sibenik, Sibenik); Ivan Bacic, Bernarda Bakmaz, Nikolina Bratošević Vučičić, Domagoj Brzic, Samir
Canovic, Emilio Dijan, Maja Grgec Dragicevic, Robert Karlo, Suzana Konjevoda, Petra Kovačević, Ivan Kovačić, Frane Markulić, Luka Matak, Jakov Mihanovic, Domagoj Morović, Gordan
Perišić, Andrea Simic, Neven Skitarelić, Matea Veršić, Vanja Žufić, Matea Zuzul (Zadar General Hospital, Zadar); Srdan Ante Anzic, Iva Carevic, Dubravka Heli Litvic, Duska
Markov-Glavas, Tatjana Savic Jovanovic (Children’s Hospital Srebrnjak, Zagreb); Goran Augustin, Jerko Biloš, Bojan Biočina, Vedrana Biosic, Dino Bobovec, Iva Botica, Boris
Bumber, Petra Čerina, Ana Danic Hadzibegovic, Katarina Duric Vukovic, Hrvoje Gasparovic, Lucija Gatin, Kresimir Grsic, Ika Gugić Radojković, Ivan Jelčić, Zeljko Kastelan, Juraj
Kolak, Tomislav Kopjar, Tomislav Kulis, Kristian Kunjko, Marjan Maric, Marcel Marjanović Kavanagh, Borna Milicic, Trpimir Morić, Miram Pasini, Luka Penezić, Drago Prgomet, Ratko
Prstacic, Andreja Prtorić, Rudolf Radojković, Ivan Romić, Tomislav Sečan, Dora Škrljak Šoša, Juraj Slipac, Mislav Tomic, Jurica Zedelj, Toni Zekulić, Zoran Zimak (University
Hospital Centre Zagreb, Zagreb); Mia Lorencin, Ivica Luksic, Matija Mamic (University Hospital Dubrava, Zagreb)



POVEZANOST RADA


Ustanove:
Klinički bolnički centar Zagreb,
Opća bolnica Zadar

Citiraj ovu publikaciju:

(COVIDSurg Collaborative ; GlobalSurg Collaborative) COVIDSurg Collaborative; GlobalSurg Collaborative
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study // Anaesthesia, 77 (2022), 1; 28-39 doi:10.1111/anae.15563 (međunarodna recenzija, članak, znanstveni)
(COVIDSurg Collaborative ; GlobalSurg Collaborative) (COVIDSurg Collaborative, GlobalSurg Collaborative) COVIDSurg Collaborative & GlobalSurg Collaborative (2022) SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia, 77 (1), 28-39 doi:10.1111/anae.15563.
@article{article, year = {2022}, pages = {28-39}, DOI = {10.1111/anae.15563}, keywords = {COVID-19, SARS-CoV-2, deep vein thrombosis, pulmonary embolism, venous thromboembolism}, journal = {Anaesthesia}, doi = {10.1111/anae.15563}, volume = {77}, number = {1}, issn = {0003-2409}, title = {SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study}, keyword = {COVID-19, SARS-CoV-2, deep vein thrombosis, pulmonary embolism, venous thromboembolism} }
@article{article, year = {2022}, pages = {28-39}, DOI = {10.1111/anae.15563}, keywords = {COVID-19, SARS-CoV-2, deep vein thrombosis, pulmonary embolism, venous thromboembolism}, journal = {Anaesthesia}, doi = {10.1111/anae.15563}, volume = {77}, number = {1}, issn = {0003-2409}, title = {SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study}, keyword = {COVID-19, SARS-CoV-2, deep vein thrombosis, pulmonary embolism, venous thromboembolism} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font